Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06587425
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-04
Brief Title:
The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced Recurrent or Metastatic CLDN182-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor:
Organization:
None